Resources

Share this article

Incidence of LE due to treating cutaneous melanoma

Joao Duprat, Larissa Campanholi
25 November 2014

<p>The rates of morbidity associated with lymphadenectomy as a treatment for cutaneous melanoma, as reported in the literature, vary due to the different methods used in the studies. As a result, it is difficult to compare data from different research (Kretschemer et al, 2008). Assessing the incidence of lymphoedema and other morbidities in patients with melanoma is important, as over time the risk of developing lymphoedema increases. </p>

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.